GSK Investigational Site

Traverse City, Michigan 49686

0 studies enrolling now · 12 studies all time

What they study most

Bowel Dysfunction, Constipation, Dyskinesias, Epilepsy, Epilepsy, Partial, Epilepsy, Tonic-Clonic, Macular Degeneration, Neoplasms, Breast, Parkinson Disease, Parkinson's Disease, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
• Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration — Completed
• A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD — Completed
• Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed
• An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease — Completed
• Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa — Completed
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Lamotrigine Extended-Release In Elderly Patients With Epilepsy — Completed
• Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures — Completed
• Treatment With Pazopanib for Neoadjuvant Breast Cancer — Completed